Melissa B. Epperly, Chief Financial Officer at Zentalis Pharmaceuticals, Inc. (ZNTL), bought 9,611 shares at $52.00 ($500K) on 2021-08-18, disclosed to the SEC on 2021-08-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.00 | 1,326 | $69K | 13.8% |
| 2 | $52.00 | 8,285 | $431K | 86.2% |
| Total | $52.00 avg | 9,611 | $500K | 100% |
| Filing → |
| ROIV | SELL | 2026-07-01 | $610K | — | Filing → |
| ROIV | SELL | 2026-03-18 | $1.2M | — | Filing → |
| ZNTL | SELL | 2024-02-12 | $29K | — | Filing → |